Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Therapeutic Potential of AntagomiR-23b for Treating Myotonic Dystrophy

Published:2020-09 Issue: Volume:21 Page:837-849
ISSN:2162-2531
Container-title:Molecular Therapy - Nucleic Acids
language:en
Short-container-title:Molecular Therapy - Nucleic Acids

Author:

Cerro-Herreros Estefanía,González-Martínez Irene,Moreno-Cervera Nerea,Overby Sarah,Pérez-Alonso Manuel,Llamusí Beatriz,Artero Rubén

Funder

“la Caixa” Banking Foundation

Instituto de Salud Carlos III

Santiago Grisolia

Precipita Project

Fondo Social Europeo

Generalitat Valenciana and co-financed with ERDF funds

Publisher

Elsevier BV

Subject

Drug Discovery,Molecular Medicine

Reference57 articles.

1. Disease burden of myotonic dystrophy type 1;Landfeldt;J. Neurol.,2019

2. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2;Mankodi;Ann. Neurol.,2003

3. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy;Miller;EMBO J.,2000

4. Short Tandem Repeat Expansions and RNA-Mediated Pathogenesis in Myotonic Dystrophy;Sznajder;Int. J. Mol. Sci.,2019

5. MBNL proteins and their target RNAs, interaction and splicing regulation;Konieczny;Nucleic Acids Res.,2014

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MBNL splicing factors regulate the microtranscriptome of skeletal muscles;Nucleic Acids Research;2024-09-11

2. Deletion of miR-146a enhances therapeutic protein restoration in model of dystrophin exon skipping;Molecular Therapy - Nucleic Acids;2024-09

3. Immortalized human myotonic dystrophy type 1 muscle cell lines to address patient heterogeneity;iScience;2024-06

4. Myotonic dystrophy type 1 (Steinert disease): 29 years of experience at a tertiary pediatric hospital;European Journal of Paediatric Neurology;2024-01

5. Peptide-conjugated antimiRs improve myotonic dystrophy type 1 phenotypes by promoting endogenous MBNL1 expression;Molecular Therapy - Nucleic Acids;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3